GSK plc
LONDON, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 5, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$497.0M2026 Q3
Positions13
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.98.1%
GSK plc reported 13 positions worth $497.0M as of September 30, 2026 (13F filed November 5, 2026). Largest holding: CRSP (29.0%). Biggest move: exit 96663EUR ($106.0M).
10 / 13 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | CRSP | $144.3M | 29.03% | 2,608,419 | — | — | -23.6% | |
| ▸ 2 | VIR | $95.6M | 19.23% | 8,550,954 | — | — | -10.9% | |
| ▸ 3 | WVE | $67.5M | 13.58% | 18,245,691 | — | — | -15.4% | |
| ▸ 4 | BNTX | $65.7M | 13.22% | 668,526 | — | — | -12.9% | |
| ▸ 5 | IDYA | $51.2M | 10.31% | 1,333,333 | — | — | -17.2% | |
| ▸ 6 | CYTK | $22.4M | 4.51% | 340,434 | — | — | -14.8% | |
| ▸ 7 | LYEL | $14.8M | 2.98% | 1,512,659 | — | — | +46.1% | |
| ▸ 8 | SPRO | $11.1M | 2.24% | 9,190,606 | — | — | -17.4% | |
| ▸ 9 | NKTX | $8.3M | 1.66% | 3,150,732 | — | — | — | |
| ▸ 10 | FULC | $6.6M | 1.33% | 1,785,714 | — | — | -1.4% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does GSK plc hold as of Q3 2026?
GSK plc reported 13 positions worth $497.0M in its Q3 2026 13F filing. Largest positions: CRSP (29.0%), VIR (19.2%), WVE (13.6%), BNTX (13.2%) and IDYA (10.3%).
What did GSK plc buy in Q3 2026?
New positions: WVE.
What did GSK plc sell in Q3 2026?
Reduced: CRSP and BNTX. Sold out entirely: 96663EUR.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.